Two Sigma Investments’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$93.5M Buy
185,547
+184,981
+32,682% +$97.8M 0.07% 338
2026
Q2
$304K Buy
+566
New +$290K ﹤0.01% 4519
2023
Q2
– Sell
-24,292
Closed -$5.88M – 3168
2023
Q1
$5.88M Buy
24,292
+14,852
+157% +$4.05M 0.02% 826
2022
Q4
$2.74M Buy
+9,440
New +$923K 0.01% 1146
2021
Q3
– Sell
-68,235
Closed -$6.65M – 4514
2021
Q2
$6.65M Sell
68,235
-111,980
-62% -$13.3M 0.02% 1023
2021
Q1
$21.1M Buy
180,215
+104,104
+137% +$12.1M 0.05% 412
2020
Q4
$8.46M Buy
76,111
+9,489
+14% +$1.16M 0.02% 668
2020
Q3
$7.91M Sell
66,622
-10,720
-14% -$1.16M 0.03% 587
2020
Q2
$8.76M Buy
77,342
+59,375
+330% +$5.84M 0.04% 437
2020
Q1
$1.2M Buy
17,967
+15,717
+699% +$1.31M 0.01% 1291
2019
Q4
$205K Sell
2,250
-13,500
-86% -$1.31M ﹤0.01% 3409
2019
Q3
$1.36M Buy
+15,750
New +$1.48M ﹤0.01% 1730
2018
Q3
– Sell
-13,549
Closed -$3.79M – 3433
2018
Q2
$3.79M Buy
+13,549
New +$2.38M 0.01% 1173
2016
Q2
– Sell
-465
Closed -$4K – 3087
2016
Q1
$4K Sell
465
-9,929
-96% -$82.9K ﹤0.01% 2743
2015
Q4
$128K Buy
+10,394
New +$285K ﹤0.01% 2542
2014
Q1
– Sell
-422
Closed -$77K – 2154
2013
Q4
$77K Buy
+422
New +$77.3K ﹤0.01% 2101

Other funds holding MDGL

Two Sigma Investments's MDGL Position: Q3 2026 in Review

Two Sigma Investments increased its Madrigal Pharmaceuticals (MDGL) stake by 32,682% in Q3 2026, buying an estimated $97.8M and bringing the position to 185,547 shares worth $93.5M. The position accounts for 0.07% of the portfolio, ranked #338.

Two Sigma Investments first reported a position in MDGL in Q4 2013 and has held it in 16 quarters since. 442 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

  • Two Sigma Investments held 185,547 shares of Madrigal Pharmaceuticals worth $93.5M as of Q3 2026.
  • Two Sigma Investments bought 184,981 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $97.8M.
  • Madrigal Pharmaceuticals made up 0.07% of Two Sigma Investments's portfolio in Q3 2026, its #338 holding.
  • Two Sigma Investments first reported a position in Madrigal Pharmaceuticals in Q4 2013 and has held it in 16 quarters since.
  • 442 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.